Risk factors of ankle osteoarthritis in the treatment of critical bone defects using ilizarov technique.


Journal

BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565

Informations de publication

Date de publication:
09 Apr 2021
Historique:
received: 17 02 2021
accepted: 30 03 2021
entrez: 10 4 2021
pubmed: 11 4 2021
medline: 15 5 2021
Statut: epublish

Résumé

Distraction osteogenesis using the Ilizarov external circular fixator has been applied in lower limb reconstructive surgery widely. The increasing ankle osteoarthritis (OA) progression and severity are often associated with the period of external fixator and the greater relative instability of the ankle joint, but few studies have quantified risk factors directly during this technique. The study was conducted on 236 patients who underwent bone transport surgery for tibias using the Ilizarov external circular fixator from 2008 to 2018. The cumulative incidence of ankle OA diagnoses in patients after the Ilizarov technique treatment was calculated and stratified by risk factors from preoperative and postoperative management. After the data were significant through the Mann-Whitney U test analyzed, odds ratios were calculated using logistic regression to describe factors associated with the OA diagnosis including gender, age, BMI, location of bone defect, diabetes, hypertension, osteoporosis, the history of metal allergy and glucocorticoid intake, the American Orthopaedic Foot & Ankle Society (AOFAS) ankle-HF scale scores, defect size (DS), the type of bone transport, the bone union time, external fixator time (EFT), and external fixator index (EFI). There were 199 males and 37 females with a mean age of 47 years (range 28-59 years). Out of 236 patients, 49 had an additional treatment for ankle OA after the Ilizarov technique treatment of bone defects (average follow-up time 2.1 years, range 1.6-4.2 years). The incidence of postoperative ankle OA was 20.8 %, with 19 patients classified as K&L grade 3 and seven patients as grade 4. The top five risk factors included double-level bone transport (OR3.79, P = 0.005), EFI > 50days/cm (OR3.17, P = 0.015), age > 45years (OR2.29, P = 0.032), osteoporosis (OR1.58, P < 0.001), BMI > 25 (OR1.34, P < 0.001). Male, BMI > 25, diabetes, osteoporosis, and AOFAS ankle-HF scale scores are the independent risk factors. Ilizarov external circular fixator is a safe and effective method of treatment for critical bone defects. The double level bone transport, EFI > 50days/cm, age > 45years, osteoporosis, BMI > 25 are the top five relevant risk factors of ankle OA. The probability of developing ankle OA among patients having three or more risk factors is 50-70 %.

Sections du résumé

BACKGROUND BACKGROUND
Distraction osteogenesis using the Ilizarov external circular fixator has been applied in lower limb reconstructive surgery widely. The increasing ankle osteoarthritis (OA) progression and severity are often associated with the period of external fixator and the greater relative instability of the ankle joint, but few studies have quantified risk factors directly during this technique.
METHODS METHODS
The study was conducted on 236 patients who underwent bone transport surgery for tibias using the Ilizarov external circular fixator from 2008 to 2018. The cumulative incidence of ankle OA diagnoses in patients after the Ilizarov technique treatment was calculated and stratified by risk factors from preoperative and postoperative management. After the data were significant through the Mann-Whitney U test analyzed, odds ratios were calculated using logistic regression to describe factors associated with the OA diagnosis including gender, age, BMI, location of bone defect, diabetes, hypertension, osteoporosis, the history of metal allergy and glucocorticoid intake, the American Orthopaedic Foot & Ankle Society (AOFAS) ankle-HF scale scores, defect size (DS), the type of bone transport, the bone union time, external fixator time (EFT), and external fixator index (EFI).
RESULTS RESULTS
There were 199 males and 37 females with a mean age of 47 years (range 28-59 years). Out of 236 patients, 49 had an additional treatment for ankle OA after the Ilizarov technique treatment of bone defects (average follow-up time 2.1 years, range 1.6-4.2 years). The incidence of postoperative ankle OA was 20.8 %, with 19 patients classified as K&L grade 3 and seven patients as grade 4. The top five risk factors included double-level bone transport (OR3.79, P = 0.005), EFI > 50days/cm (OR3.17, P = 0.015), age > 45years (OR2.29, P = 0.032), osteoporosis (OR1.58, P < 0.001), BMI > 25 (OR1.34, P < 0.001). Male, BMI > 25, diabetes, osteoporosis, and AOFAS ankle-HF scale scores are the independent risk factors.
CONCLUSIONS CONCLUSIONS
Ilizarov external circular fixator is a safe and effective method of treatment for critical bone defects. The double level bone transport, EFI > 50days/cm, age > 45years, osteoporosis, BMI > 25 are the top five relevant risk factors of ankle OA. The probability of developing ankle OA among patients having three or more risk factors is 50-70 %.

Identifiants

pubmed: 33836698
doi: 10.1186/s12891-021-04214-8
pii: 10.1186/s12891-021-04214-8
pmc: PMC8035717
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

339

Subventions

Organisme : Natural Science Foundation of Xinjiang
ID : NO.2020D01C250
Organisme : National Natural Science Foundation of China
ID : NO. 81560357

Références

Foot Ankle Clin. 2013 Sep;18(3):411-26
pubmed: 24008208
Clin Orthop Relat Res. 2012 Oct;470(10):2864-73
pubmed: 22777590
Bone Res. 2017 Jan 17;5:16044
pubmed: 28149655
BMC Musculoskelet Disord. 2020 Feb 6;21(1):80
pubmed: 32028924
Osteoarthritis Cartilage. 2016 Apr;24(4):688-97
pubmed: 26596790
Foot Ankle Int. 2015 May;36(5):547-55
pubmed: 25511757
Osteoarthritis Cartilage. 2015 Jun;23(6):940-8
pubmed: 25655679
Int Orthop. 2020 May;44(5):957-963
pubmed: 32114659
Int Orthop. 2012 Aug;36(8):1695-700
pubmed: 22581353
BMC Musculoskelet Disord. 2020 Jun 6;21(1):354
pubmed: 32505174
Bull Hosp Jt Dis Orthop Inst. 1988 Spring;48(1):1-11
pubmed: 2840141
Surg Technol Int. 2019 Jun 25;35:280-294
pubmed: 31237341
J Bone Joint Surg Am. 1995 Dec;77(12):1867-75
pubmed: 8550655
Osteoarthritis Cartilage. 2009 Feb;17(2):182-7
pubmed: 18691910
Injury. 2017 Jul;48(7):1678-1683
pubmed: 28438418
Injury. 2018 Sep;49 Suppl 2:S60-S64
pubmed: 30219149
Arch Orthop Trauma Surg. 2020 Jun 11;:
pubmed: 32529385
Subcell Biochem. 2019;91:123-159
pubmed: 30888652
J Rheumatol. 2005 Jun;32(6):1147-9
pubmed: 15977351
J Athl Train. 2017 Jun 2;52(6):491-496
pubmed: 27145096
Osteoarthritis Cartilage. 2011 Nov;19(11):1270-85
pubmed: 21907813
J Bone Joint Surg Am. 2005 Feb;87(2):302-9
pubmed: 15687151
Ann Rheum Dis. 1957 Dec;16(4):494-502
pubmed: 13498604
Injury. 2020 Jun;51(6):1352-1361
pubmed: 32327233
Bone Joint J. 2015 Jan;97-B(1):76-82
pubmed: 25568417
J Athl Train. 2019 Mar;54(3):270-275
pubmed: 30829538
Arch Orthop Trauma Surg. 2020 Aug 29;:
pubmed: 32860565
J Orthop. 2019 Jan 04;16(1):91-96
pubmed: 30662246
Foot Ankle. 1986 Aug;7(1):49-61
pubmed: 3091461
Foot Ankle Int. 2015 Apr;36(4):360-8
pubmed: 25358807
Foot Ankle Int. 2021 Feb;42(2):243-244
pubmed: 33334140
Knee Surg Sports Traumatol Arthrosc. 2020 Mar;28(3):790-796
pubmed: 30887068
Clin Orthop Relat Res. 2001 Oct;(391):33-44
pubmed: 11603688
Arch Orthop Trauma Surg. 2020 Jul 30;:
pubmed: 32734449
Osteoarthritis Cartilage. 2015 Mar;23(3):363-9
pubmed: 25463444
J Orthop Res. 2017 Mar;35(3):397-405
pubmed: 27306867
J Bone Joint Surg Am. 2006 Mar;88 Suppl 1 Pt 1:119-34
pubmed: 16510806
Foot Ankle Int. 2012 Nov;33(11):964-8
pubmed: 23131442

Auteurs

Kai Liu (K)

Department of Trauma and Microreconstructive Surgery, The First Affiliated Hospital of Xinjiang Medical University, 830054, Urumqi, Xinjiang, China.

Feiyu Cai (F)

Department of Trauma and Microreconstructive Surgery, The First Affiliated Hospital of Xinjiang Medical University, 830054, Urumqi, Xinjiang, China.

Yanshi Liu (Y)

Department of Trauma and Microreconstructive Surgery, The First Affiliated Hospital of Xinjiang Medical University, 830054, Urumqi, Xinjiang, China.

Alimujiang Abulaiti (A)

Department of Trauma and Microreconstructive Surgery, The First Affiliated Hospital of Xinjiang Medical University, 830054, Urumqi, Xinjiang, China.

Peng Ren (P)

Department of Trauma and Microreconstructive Surgery, The First Affiliated Hospital of Xinjiang Medical University, 830054, Urumqi, Xinjiang, China. rpsky@126.com.

Aihemaitijiang Yusufu (A)

Department of Trauma and Microreconstructive Surgery, The First Affiliated Hospital of Xinjiang Medical University, 830054, Urumqi, Xinjiang, China. ahmatjang@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH